Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2022 Earnings Call Transcript November 10, 2022
Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.97, expectations were $-1.05.
Operator: Ladies and gentlemen, welcome to the Iterum Therapeutics Third Quarter 2022 Financial Results Call. My name is Maxine, and I’ll be coordinating the call today. I will now hand you over to Louise Barrett, SVP of Legal Affairs to begin. Louise, please go ahead when you’re ready.
Louise Barrett:...
